Worse Survival Observed Among Patients Diagnosed with Cancer During the First 2 Years of the COVID-19 Pandemic By Ogkologos - February 16, 2026 120 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the US cohort study Source RELATED ARTICLESMORE FROM AUTHOR EMA Adopts a Positive Opinion for a New Route of Administration Together with a New Pharmaceutical Form and a New Strength for Isatuximab National Study Examines Genetic Testing to Inform Follow-up Care for Cancer Survivors Taletrectinib Demonstrates Durable Long-Term Efficacy in Both TKI-naïve and Crizotinib-pretreated Patients with Advanced ROS1-positive NSCLC MOST POPULAR Longer Duration of Treatment with ICIs Associated with a Higher Rate... March 5, 2025 Woman Donates 500 Care Packages To Breast Cancer Patients October 11, 2021 Longer PFS in Patients with Advanced Melanoma Treated with TILs than... December 14, 2022 ESMO Targeted Anticancer Therapies Congress 2025, Paris, France, 3-5 March February 24, 2025 Load more HOT NEWS Enhertu Marks First Targeted Therapy for HER2-Mutant Lung Cancer Atezolizumab Approved for Some Patients with Triple-Negative Breast Cancer How Clinical Trials Can Lead to Life-Saving Treatment: The TAPUR Trial... Adjuvant Dabrafenib Plus Trametinib Associated with Better RFS and DMFS than...
